Breast cancer (BC) is the second incidence and the fifth leading cause to cancer death in the worldwide. In developing countries, the number of BC cases is still increased annually accompanied with the changes of lifestyle and screening programs. Nevertheless, the majority of BC patients are diagnosed as non-curative stage. Thereby, systemic therapy always plays an important role in BC treatment strategies. Among chemotherapy regimens, the combination of anthracyclin and taxane as an adjuvant treatment has been proven the efficacy and safety in terms of prolonging survival. In this study, we evaluated the incidence of chemotherapy-induced amenorrhea in breast cancer patients who were treated with adjuvant anthracycline and taxane-based chemotherapy.
Cite this paper
Quang, N. T. , Anh, P. T. , Quang, L. V. , Hai, N. V. , Huan, N. D. , Tin, N. C. , Tam, N. T. T. , Hang, H. T. , Thuy, N. T. , Mai, D. T. T. , Nam, T. H. and Hanga, L. T. (2020). Incidence of Chemotherapy-Induced Amenorrhea in Premenopausal Patients with Breast Cancer Following Adjuvant Chemotherapy with Anthracycline and Taxane. Open Access Library Journal, 7, e5999. doi: http://dx.doi.org/10.4236/oalib.1105999.
Fornier, M.N., Modi, S., Panageas, K.S., Norton, L. and Hudis, C. (2005) Incidence of Chemotherapy-Induced, Long-Term Amenorrhea in Patients with Breast Carcinoma Age 40 Years and Younger after Adjuvant Anthracycline and Taxane. Cancer, 104, 1575-1579. https://acsjournals.onlinelibrary.wiley.com/d oi/full/10.1002/cncr.21385 https://doi.org/10.1002/cncr.21385
Walshe, J.M., Denduluri, N. and Swain, S.M. (2006) Amenorrhea in Premenopausal Women after Adjuvant Chemotherapy for Breast Cancer. Journal of Clinical Oncology, 24, 5769-5779. https://ascopubs.org/doi/abs/10.1200/JCO.20 06.07.2793?journalCode=jco https://doi.org/10.1200/JCO.2006.07.2793
Jeon, S.J., Lee, J.I., Jeon, M.J. and Lee M. (2016) Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients. Medicine, 95, e3301. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998816/ https://doi.org/10.1097/MD.0000000000003301
Giuliano, A.E., Haigh, P.I., Brennan, M.B., Hansen, N.M., Kelley, M.C., Ye, W., Glass, E.C. and Turner, R.R. (2000) Prospective Observational Study of Sentinel Lymphadenectomy without Further Axillary Dissection in Patients with Sentinel Node-Negative Breast Cancer. Journal of Clinical Oncology, 18, 2553-2559. https://ascopubs.org/doi/10.1200/JCO.2000.18.13.2553 https://doi.org/10.1200/JCO.2000.18.13.2553
Choi, S.H., Barsky, S.H. and Chang, H.R. (2003) Clinicopathologic Analysis of Sentinel Lymph Node Mapping in Early Breast Cancer. The Breast Journal, 9, 153-162. https://onlinelibrary.wiley.com/doi/abs/10.1 046/j.1524-4741.2003.09304.x https://doi.org/10.1046/j.1524-4741.2003.09304.x
Tham, Y.L., Sexton, K., Weiss, H., Elledge, R., Friedman, L.C. and Kramer, R. (2007) The Rates of Chemotherapy-Induced Amenorrhea in Patients Treated with Adjuvant Doxorubicin and Cyclophosphamide Followed by a Taxane. American Journal of Clinical Oncology, 30, 126-132. https://insights.ovid.com/crossref?an=000 00421-200704000-00004 https://doi.org/10.1097/01.coc.00002513 98.57630.4f
Berliere, M., Dalenc, F., Malingret, N., Vindevogel, A., Piette, P., Roche, H., Donnez, J., Symann, M, Kerger, J. and Machiels, P. (2008) Incidence of Reversible Amenorrhea in Women with Breast Cancer Undergoing Adjuvant Anthracycline-Based Chemotherapy with or without Docetaxel. BMC Cancer, 8, 56. https://bmccancer.biomedcentral.com/arti cles/10.1186/1471-2407-8-56 https://doi.org/10.1186/1471-2407-8-56
Goldhirsch, A., Gelber, R.D. and Castiglione, M. (1990) The Magnitude of Endocrine Effects of Adjuvant Chemotherapy for Premenopausal Breast Cancer Patients. Annals of Oncology, 1, 183-188. https://academic.oup.com/annonc/article-abst ract/1/3/183/146536?redirectedFrom=fulltext https://doi.org/10.1093/oxfordjournals.annonc.a 057718